The role of the PPAR system in diabetic cardiovascular risk and beyond
These diversified effects, albeit with a limited risk of significant side effects, make PPAR agonists an area of growing interest and with an expanding range of potential applications.
Authors
- Massimiliano Ruscica (ORCID: https://orcid.org/0000-0002-0195-7061)
- Chiara Macchi (ORCID: https://orcid.org/0000-0002-5919-989X)
- Alberto Corsini (ORCID: https://orcid.org/0000-0002-9912-9482)
- Cesare R. Sirtori
Institutions
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Ospedale Maggiore (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Current Opinion in Endocrinology Diabetes and Obesity
- Published
- 2025-11-19
- DOI
- https://doi.org/10.1097/med.0000000000000943
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00